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Role of Cj1211 in Natural Transformation and Transfer of Antibiotic
Resistance Determinants in Campylobacter jejuni
Abstract
Campylobacter jejuni, an important food-borne human pathogen, is increasingly resistant to antimicrobials.
Natural transformation is considered to be a main mechanism for mediating the transfer of genetic materials
encoding antibiotic resistance determinants in C. jejuni, but direct evidence for this notion is still lacking. In
this study, we determined the role of Cj1211 in natural transformation and in the development of antibiotic
resistance in C. jejuni. Insertional mutagenesis of Cj1211, a Helicobacter pylori ComH3 homolog, abolished
natural transformation in C. jejuni. In vitro coculture of C. jejuni strains carrying either kanamycin or
tetracycline resistance markers demonstrated the development of progenies that were resistant to both
antibiotics, indicating that the horizontal transfer of antibiotic resistance determinants actively occurs in
mixed Campylobacter populations. A mutation of Cj1211 or the addition of DNase I in culture media
completely inhibited the formation of progenies that were resistant to both antibiotics, indicating that the
horizontal transfer of the resistance determinants is mediated by natural transformation. Interestingly, the
mutation of Cj1211 also reduced the frequency of emergence of spontaneous mutants that were resistant to
fluoroquinolone (FQ) and streptomycin but did not affect the outcome of FQ resistance development under
FQ treatment, suggesting that natural transformation does not play a major role in the emergence of FQ-
resistant Campylobacter strains during treatment with FQ antimicrobials. These results define Cj1211 as a
competence factor in Campylobacter, prove the role of natural transformation in the horizontal transfer of
antibiotic resistance determinants in Campylobacter, and provide new insights into the mechanism underlying
the development of FQ-resistant Campylobacter strains.
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Campylobacter jejuni, an important food-borne human pathogen, is increasingly resistant to antimicrobials.
Natural transformation is considered to be a main mechanism for mediating the transfer of genetic materials
encoding antibiotic resistance determinants in C. jejuni, but direct evidence for this notion is still lacking. In
this study, we determined the role of Cj1211 in natural transformation and in the development of antibiotic
resistance in C. jejuni. Insertional mutagenesis of Cj1211, a Helicobacter pylori ComH3 homolog, abolished
natural transformation in C. jejuni. In vitro coculture of C. jejuni strains carrying either kanamycin or
tetracycline resistance markers demonstrated the development of progenies that were resistant to both anti-
biotics, indicating that the horizontal transfer of antibiotic resistance determinants actively occurs in mixed
Campylobacter populations. A mutation of Cj1211 or the addition of DNase I in culture media completely
inhibited the formation of progenies that were resistant to both antibiotics, indicating that the horizontal
transfer of the resistance determinants is mediated by natural transformation. Interestingly, the mutation of
Cj1211 also reduced the frequency of emergence of spontaneous mutants that were resistant to fluoroquinolone
(FQ) and streptomycin but did not affect the outcome of FQ resistance development under FQ treatment,
suggesting that natural transformation does not play a major role in the emergence of FQ-resistant Campy-
lobacter strains during treatment with FQ antimicrobials. These results define Cj1211 as a competence factor
in Campylobacter, prove the role of natural transformation in the horizontal transfer of antibiotic resistance
determinants in Campylobacter, and provide new insights into the mechanism underlying the development of
FQ-resistant Campylobacter strains.
Campylobacter jejuni is a gram-negative organism and a ma-
jor food-borne human pathogen that causes more than 2 mil-
lion cases of campylobacteriosis in the United States each year
(38). Infection with Campylobacter often results in diarrhea,
fever, and abdominal cramps. Post-Campylobacter infection is
also associated with Guillain-Barre´ syndrome, an acute demy-
elinating disease of the peripheral nervous system (27, 67).
Antibiotic therapy is necessary when Campylobacter infections
are prolonged or severe or when they occur in immunocom-
promised hosts. However, Campylobacter resistance to various
antibiotics is on the rise and has become a concern for public
health (20, 44).
Bacteria acquire antibiotic resistance by mutations and hor-
izontal gene transfer (9, 34, 40, 52). Mutations in the genes
encoding antibiotic targets help bacteria counteract the attack
by antibiotics. For example, point mutations in gyrA, rpoB, and
rpsL result in resistance to fluoroquinolone, rifampin, and
streptomycin, respectively (34). Horizontal gene transfer is me-
diated by transduction, conjugation, and natural transforma-
tion (40). Transduction is carried out by bacteriophages, while
conjugation is mediated by self-replicating plasmids and re-
quires cell-to-cell contact (18, 52). Unlike transduction and
conjugation, natural transformation does not require bacterio-
phages or cell-to-cell contact. Instead, natural transformation
involves the uptake of free DNA from the surrounding envi-
ronment by some competent bacterial species and subsequent
homologous recombination to incorporate the internalized
DNA into the recipient chromosome (8, 15, 52). Most bacteria
possess at least one of the mechanisms for the horizontal
transfer of genetic materials (52).
Campylobacter is capable of conjugation and natural trans-
formation (53, 59). Conjugative transfer of antibiotic resis-
tance, often resistance to tetracycline, was reported in Campy-
lobacter in culture media and in infected animals (2, 48, 53, 56).
Natural transformation is well recognized in Campylobacter
and has facilitated the genetic manipulation of Campylobacter
strains for research purposes (24, 59, 60). The natural compe-
tence of Campylobacter is widely regarded as an important
mechanism to generate genetic diversity of this bacterium by
mediating horizontal gene transfer (10, 12, 17, 32, 62). It ap-
pears that both natural transformation and conjugation poten-
tially play significant roles in the transfer of antibiotic resis-
tance determinants in Campylobacter. Bacteriophages infecting
different Campylobacter strains have been reported (1, 21, 30),
but their role in mediating horizontal gene transfer in Campy-
lobacter is unknown.
Bacterial competence for natural transformation requires
the function of a series of proteins involved in DNA binding,
fragmentation, degradation, and transport (8, 14). During the
process of natural transformation, the transforming DNA must
pass through the hydrophobic membrane barrier to enter the
cytosol, and this transmembrane passage is mediated by cyto-
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plasmic membrane channel proteins (8, 15). In both gram-
negative and gram-positive bacteria, several competence pro-
teins such as Helicobacter pylori ComE3, Neisseria gonorrhoeae
ComA, Streptococcus pneumoniae CelB, Haemophilus influen-
zae Rec-2, and Bacillus subtilis ComEC have been reported to
play a critical role in natural transformation by facilitating the
transfer of extracellular DNA to the cytosol (16, 25, 41, 46, 66).
In B. subtilis, ComEC functions as homodimers in the mem-
brane and forms an aqueous channel through which transform-
ing DNA enters the cytosol (13). In H. pylori, the ComE3
protein (a ComEC homolog) is speculated to be a membrane
transporter involved in DNA transfer (66). Several compe-
tence factors in C. jejuni have been identified, including RecA,
involved in DNA recombination (23); VirB10, encoded by the
pVir plasmid (3, 4); ComEA (Cj0011c), involved in DNA bind-
ing (29); and several proteins of the type II secretion pathway
(61) and the N-linked protein glycosylation pathway (35). In
spite of these advances in our understanding of the natural
transformation of Campylobacter, little is known about the
detailed mechanisms involved in the uptake of DNA through
the outer membrane, processing of DNA in the periplasm, and
transfer of DNA from the periplasm to the cytosol. Based on
the genomic sequence of C. jejuni strain NCTC 11168 (43),
Cj1211 shares significant amino acid sequence homology (33%
identity; E  5e-34) with H. pylori ComE3, a putative mem-
brane channel protein involved in the transfer of DNA (66).
However, the role of Cj1211 in the natural transformation of
C. jejuni is unknown. In addition, the contribution of natural
transformation to the horizontal transfer of antibiotic resis-
tance determinants and to the emergence of fluoroquinolone
(FQ) resistance in C. jejuni has not been formally demon-
strated. In this study, we conducted both in vitro and in vivo
experiments to address these questions.
MATERIALS AND METHODS
Bacterial strains and culturing conditions. C. jejuni NCTC 11168 and its de-
rivatives were used in this study (Table 1). The strains were grown in Mueller-Hinton
(MH) medium under microaerobic (5% O2, 10% CO2, and 85% N2) conditions at
42°C. When needed, the culture media were supplemented with kanamycin (50 g
ml1), tetracycline (5 g ml1), or chloramphenicol (10 g ml1).
Construction of various mutants. A Cj1211 mutant was constructed by insert-
ing the cat gene into the middle of Cj1211. A 1,555-bp fragment containing
Cj1211 was PCR amplified with VentR DNA polymerase (New England Biolabs,
Ipswich, MA) using primers Cj1211_F and Cj1211_R (Table 2). The PCR prod-
uct was cloned into SmaI-digested pUC19. pUC19 containing Cj1211 was di-
gested with SwaI and ligated with cat, which was amplified from pUOA18 (58)
with primers Cat_F and Cat_R (Table 2). The orientation of the inserted cat
gene was confirmed by PCR. The plasmid was electroporated into C. jejuni
NCTC 11168, and the Cj1211::cat mutant was selected on MH agar plates
containing chloramphenicol (10 g ml1). The Cj1211 mutant was confirmed by
PCR and was designated JB201 in this study (Table 1).
To facilitate the measurement of the horizontal transfer of antibiotic resis-
tance determinants in Campylobacter, two C. jejuni NCTC 11168 mutants har-
boring different antibiotic markers were constructed. The hipO mutant was
constructed by the insertion of the aphA3 gene, encoding kanamycin resistance,
into hipO. For this purpose, the DNA region containing the hipO gene was
amplified with Ex Taq (TaKaRa Bio Inc., Japan) using primers hipO_F and
hipO_R (Table 2) and cloned into pGEM-T (Promega, Madison, WI).
pGEM-T::hipO was digested with NheI and blunt ended with Klenow fragment
(TaKaRa Bio Inc.). This construct was ligated with aphA3 DNA, which was
amplified with VentR DNA polymerase (New England Biolabs) from pMW10
(63) by use of primers Kan_F and Kan_R (Table 2). The resulting plasmid was
used as a suicide vector and introduced into C. jejuni by electroporation. The
transformants were selected on MH agar plates supplemented with kanamycin
(30 g ml1). The hipO mutant was confirmed by PCR and named JB202 (Table
1). C. jejuni strain BQ304, in which the tet(O) gene (encoding tetracycline
resistance) was inserted into dcuA (B. Guo and Q. Zhang, unpublished data),
was also used in this study (Table 1). The hipO mutant and the dcuA mutant were
further used to generate JB203 and JB204 (Table 1). JB203 was generated by the
transformation of JB202 using genomic DNA of JB201, and JB204 (Table 1) was
TABLE 1. C. jejuni strains and plasmids used in this study
C. jejuni strain
or plasmid Description
Source or
reference
Strains
NCTC 11168 Wild type 43
JB101 NCTC 11168 derivative;
Cj0011c::cat
29
JB201 NCTC 11168 derivative;
Cj1211::cat
This study
JB201C JB201 harboring pJB1211 This study
JB201P JB201 harboring pRY108 This study
JB202 NCTC 11168 derivative;
hipO::kan
This study
BQ304 NCTC 11168 derivative;
dcuA::tet(O)
Our laboratory
JB203 NCTC 11168 derivative;
Cj1211::cat hipO::kan
This study
JB204 NCTC 11168 derivative;
Cj1211::cat dcuA::tet(O)
This study
Plasmids
pUOA18 E. coli-Campylobacter shuttle
plasmid; Cmr
58
pMW10 E. coli-Campylobacter shuttle
plasmid; Kanr
63
pRY108 E. coli-Campylobacter shuttle
plasmid; Kanr
65
pJB1211 pRY108 derivative;
pRY108::Cj1211
This study
TABLE 2. Primers used in this study
Primer Sequence (5–3)a
Cj1211_F..............GCTGCAGGAGTTTTAAGTTCTCAAGGAAAA
Cj1211_R.............GAGCAAATCTCCATAGTTTATAAGATGCAA
AAATAA
Cat_F ...................CTAACTTCCGGTGAAGGATATCTAGAAAAA
Cat_R...................GCCCATTCTATAGATATATGGATCCGC
GCGC
hipO_F.................CACAATATGCCTTTTGGTAGCGATAAGAAA
hipO_R ................CGCAAGTTTACAGAATTTACAAGAACTT
TTTG
Kan_F ..................CTTATCAATATATCCATGGAATGGGCAAA
GCAT
Kan_R..................GATAGAACCATGGATAATGCTAAGACAATC
ACTAAA
Cj1211_UF ..........CATCATTTTGCTGCTTTTCTAGATCATT
GCTA (XbaI)
Cj1211_UR..........AAAAGAGTAAGAAAAAGAATTCCATAGAG
ACATTAATAGCCTTTAAAAAAATATTATC
TTATGTATG
Cj1211_DF ..........ATGTCTCTATGGAATTCTTTTTCTTACTC
TTTT
Cj1211_DR..........GGATTTAGAATTCTTGGATTATTTATCTTTT
TGGG (EcoRI)
Cj1211RT_R .......GATAATTCCATGGCTCAAAAATTGATTCTT
GCTTAAA
a Restriction sites embedded in the primers are underlined and indicated in
parentheses.
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constructed by transforming BQ304 with the genomic DNA of JB201. Detailed
information on these mutants is described in Table 1. The selection of the hipO
and dcuA mutants was based on three criteria. First, the inactivation of these
genes must not influence the natural transformation of C. jejuni. Second, the
growth of one mutant should not suppress the growth of the other in bacterial
cocultures. Third, these mutants must carry different antibiotic resistance mark-
ers. The hipO mutant was previously used for a natural transformation study of
Campylobacter by other investigators (10). The dcuA mutant carried an antibiotic
marker different from that of the hipO mutant, and JB201 and was readily
available in our laboratory. Both the hipO and dcuA mutants did not affect the
natural transformation in C. jejuni (see Fig. S1 in the supplemental material) and
met the criteria mentioned above.
Complementation of the Cj1211 mutant. Cj1211 and its three upstream genes
appear to form an operon (Fig. 1A). There is a predicted promoter in the
intergenic region between Cj1207c and Cj1208 (Fig. 1B), and this promoter was
fused with Cj1211 for complementation of the Cj1211 mutant. A 173-bp inter-
genic region between Cj1207c and Cj1208 was amplified with primers Cj1211_UF
and Cj1211_UR (Table 2). The entire coding sequence of Cj1211 was PCR
amplified with primers Cj1211_DF and Cj1211_DR (Table 2). Primer
Cj1211_UR was designed to contain a sequence (33 bp) overlapping that of
primer Cj1211_DF (Table 2). After the purification of PCR products with the
QIAQuick PCR purification kit (Qiagen, Valencia, CA), these two PCR prod-
ucts were PCR ligated by taking advantage of the overlapped sequence as an
annealing region. The ligated product was digested by XbaI and EcoRI and then
cloned into pRY108, which is an Escherichia coli-C. jejuni shuttle plasmid (65).
pRY108 harboring Cj1211 was transferred into JB201 cells by conjugation (39),
which resulted in the creation of JB201C (Table 1). As shown in Fig. 1C, the
complementation restored the expression of Cj1211 in JB201C cells. RT-PCR
was performed with primers Cj1211_DF and Cj1211RT_R (Table 2).
Natural transformation. Natural transformation was done according to a
method described previously (59). The donor DNA was isolated from the
Cj0011c mutant (designated JB101 in this study) and BQ304 (Table 1). Both
mutant strains were readily available in our laboratory, and their antibiotic
resistance markers, aphA3 and tet(O), confer resistance to kanamycin and tetra-
cycline, respectively, making them suitable for use as donor DNA in transfor-
mation experiments. Transformants were selected on MH agar plates containing
tetracycline (5 g ml1) or kanamycin (30 g ml1). The transformation fre-
quency was defined as the number of transformants per 1 g of DNA divided by
the total bacterial number. The transformation experiment with BQ304 DNA
was done twice, while the experiment with JB101 DNA was repeated three times.
Each transformation experiment was performed in triplicate.
Assay of DNA binding and uptake. DNA binding and uptake were assessed as
previously described (61). Briefly, 1.2 g of chromosomal DNA from C. jejuni
NCTC 11168 was nick translated using the Roche (Basel, Switzerland) nick
translation kit in the presence of 40 Ci [-33P]dCTP as recommended by the
manufacturer. The 33P-labeled DNA was washed by ethanol precipitation and
resuspended in TE (10 mM Tris, 1 mM EDTA [pH 8.0]). C. jejuni strains were
grown on MH agar plates overnight. C. jejuni cells were washed three times with
MH broth and resuspended to an optical density at 600 nm (OD600) of 0.5.
Labeled DNA (100 ng) was added to 1 ml of bacterial suspension. After mi-
croaerobic incubation at 37°C for 30 min, half of the bacterial suspension (500 l)
was treated with DNase I (100 g ml1) for 10 min at room temperature. The
DNase I-treated and nontreated suspensions were washed three times and re-
suspended in MH broth. Each sample was mixed with 5 ml Ecoscint H liquid
scintillation fluid (National Diagnostics, Atlanta, GA) by vigorous shaking for
15 s. Beta emission from 33P was detected by automated liquid scintillation
(Beckman Coulter, Fullerton, CA). The radioactivities from DNase I-treated
and nontreated samples indicate the levels of DNA uptake and binding, respec-
tively. Triplicate treatments were prepared for each experiment, and the exper-
iment was repeated three times.
DNA exchange in bacterial cocultures. The coculture experiment was done to
investigate the role of Cj1211 in mediating DNA transfer during bacterial
growth. Cultures of C. jejuni grown overnight on MH agar plates were collected
and resuspended in fresh MH broth to an OD600 of 0.05. For measuring DNA
transfer in the Cj1211 background, where C. jejuni contains the intact Cj1211,
a bacterial suspension of JB202 (Kanr) was mixed with an equal volume of
BQ304 (Tetr). The tubes were cultured microaerobically at 37°C with shaking
(200 rpm). Samples were taken at 0, 3, 8, and 24 h and plated onto MH agar
plates containing kanamycin (30 g ml1), tetracycline (5 g ml1), or both. To
measure DNA transfer in the Cj1211 background, where Cj1211 was inacti-
vated, equal volumes of JB203 (Kanr Cmr) and JB204 (Tetr Cmr) were mixed,
and the mixture was cultured and sampled as described above. In some experi-
ments, bacterial cultures were washed with MH broth prior to preparation of the
mixture to remove free DNA in the inocula. This washing step was done by
centrifugation (13,000  g for 1 min) and was repeated five times. The washed
bacterial cells were then mixed for the coculture experiment. To determine the
involvement of free DNA in the transfer, DNase I was added to the mixed
culture at a concentration of 30 g ml1 in some experiments. The enzyme was
added at the beginning of the coculture experiment. Each experiment was per-
formed with three technical replicates and repeated three times.
Frequency of spontaneous mutations in the Cj1211 mutant. To determine the
effect of the Cj1211 mutation on the emergence of spontaneous mutants, cultures
of JB201 and wild-type NCTC 11168 grown overnight on MH agar plates were
resuspended in MH broth to an OD600 of 0.07. The bacterial suspensions were
incubated at 37°C with shaking (200 rpm) for 4 h (OD600  0.3), and the
bacterial suspensions were spread onto MH agar plates containing ciprofloxacin
(1 g ml1) (4 the MIC) or streptomycin (3 g ml1) (3 the MIC) to assess
the numbers of spontaneous mutants that were resistant to ciprofloxacin or
streptomycin. Total bacterial counts were also determined by plating onto MH
agar plates without antibiotics. The frequency of spontaneous mutation was
calculated by dividing the bacterial count on MH agar plates containing antibi-
otics by the total bacterial count.
Development of FQ-resistant (FQr) mutants under in vitro antibiotic treat-
ment. Cultures of wild-type NCTC 11168 and JB201 grown overnight were
resuspended in MH broth to an OD600 of 0.05. The bacterial suspensions were
cultured microaerobically at 37°C with shaking (200 rpm). Afer 8 h of incubation,
ciprofloxacin was added to the media at a final concentration of 1 g ml1, and
the cultures were continuously incubated for another 40 h. At 0, 3, 8, 24, and 48 h
after the start of the incubation, bacterial samples (100 l each) were taken and
spread onto MH agar plates containing ciprofloxacin (1 g ml1) to enumerate
the number of FQr mutant. The total bacterial number was also counted by serial
dilutions of the samples and plating onto MH agar plates without antibiotics.
Development of FQr mutants under in vivo antibiotic treatment. Five-day-old
chickens were divided into two groups, and each group consisted of 10 chickens.
One group was inoculated with wild-type NCTC 11168, and the other was
inoculated with JB201. Each chicken received approximately 1  10 6 CFU of C.
jejuni, which were freshly grown in MH broth overnight. Before inoculation, the
absence of Campylobacter in the chickens was confirmed by culturing cloacal
swabs on MH agar plates containing Campylobacter-selective supplements
(SR0232E and SR0117E; Oxoid). Six days after the inoculation, enrofloxacin
treatment was initiated, and the antibiotic was given in drinking water (50 mg
liter1) for 5 days. The medicated water was prepared and replaced daily. Fecal
FIG. 1. Transcription unit of Cj1211. (A) Genomic organization of
Cj1211 and its flanking genes. Open reading frames and their tran-
scription directions are indicated by boxed arrows. The location of the
cat insertion in JB201 is indicated with a bracket above Cj1211. The
predicted RpoD promoter upstream of Cj1208 is indicated with a
curved arrow. (B) Predicted promoter sequences upstream of Cj1208.
The 10, 16, and 35 regions and the ribosomal binding site (RBS)
are underlined. The start codons of Cj1208 and Cj1207c are boxed.
(C) RT-PCR analysis of the transcription of Cj1211 in wild-type NCTC
11168 (WT), JB201, and JB201C.
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samples were collected with cloacal swabs, diluted with MH broth, and plated
onto MH agar plates containing Campylobacter-selective supplements. In addi-
tion, each sample was also plated onto MH agar plates containing ciprofloxacin
(4 g ml1) to count FQr isolates. Representative isolates from each group were
randomly selected, used in PCR to confirm the Cj1211 mutation, and tested for
MICs of ciprofloxacin using the Etest (AB Biodisk, Solna, Sweden). The differ-
ences in the emergence of FQr mutants between the wild type and JB201 at each
sampling time point were compared with a Student’s t test.
RESULTS
Identification of Cj1211 as a potential competence protein.
According to the genomic sequence of C. jejuni NCTC 11168
(43), Cj1211 is predicted to be an integral membrane protein
and shares 33% identity and 53% similarity to H. pylori
ComE3. However, it has low overall homology (less than 15%
identity) with other functionally defined ComE3 orthologs
such as B. subtilis ComEC, N. gonorrhoeae ComA, S. pneu-
moniae CelB, and H. influenzae Rec-2. Despite the low overall
homology with other ComE3 orthologs, the putative compe-
tence domain, which was previously described for B. subtilis
ComEC (13), was relatively conserved (23% identity and 39%
similarity with B. subtilis ComEC, 19% identity and 36% sim-
ilarity with N. gonorrhoeae ComA, and 38% identity and 58%
similarity with H. pylori ComE3) (Fig. 2). C. jejuni Cj1211 has
419 amino acids, which is similar in size to the ComE3 (417
amino acids) of H. pylori. However, other ComE3 homologs
are larger, with approximately 700 amino acids. A motif search
(http://smart.embl-heidelberg.de/) showed that the C-terminal
regions of B. subtilis ComEC, N. gonorrhoeae ComA, and H.
influenzae Rec-2 contain a lactamase B domain (7), whereas
this domain was absent in C. jejuni Cj1211, H. pylori ComE3,
and S. pneumoniae CelB, suggesting possible functional varia-
tions among these proteins. Cj1211 was annotated as an inte-
gral membrane protein (43). Predictions by multiple programs
including PSORTb v.2.0 (http://www.psort.org/psortb/index
.html), CELLO v.2.5 (http://cello.life.nctu.edu.tw/), PSLpred
(http://www.imtech.res.in/raghava/pslpred/), and Gneg-PLoc
(http://202.120.37.186/bioinf/Gneg/) suggested that Cj1211 is a
possible inner membrane protein (data not shown). Other C.
jejuni strains and Campylobacter species such as C. jejuni
RM1221, C. jejuni 81116, C. coli, C. upsaliensis, C. lari, C.
curvus, C. concisus, and C. fetus possess proteins homologous
to Cj1211 (data not shown), suggesting that Cj1211 is highly
conserved among campylobacters. Interestingly, the published
genomic sequences of C. jejuni 81-176 (NCBI accession num-
ber NC_008787) and C. jejuni doylei 269.97 (accession number
NC_009707) did not identify a Cj1211 homolog. However,
analysis of the genomic sequences indicated that these two
strains possess the DNA sequences encoding proteins ho-
mologous to Cj1211 (99% and 97% amino acid identities,
respectively). The Cj1211 homologs are located between
CJJ81176_1224 and yihY in C. jejuni 81-176 and between
JJD26997_0518 and JJD26997_0519 in C. jejuni doylei
269.97. The reason that Cj1211 was not annotated in these
two strains was unknown.
The Cj1211 gene appears to be positioned in an operon with
three upstream genes (Cj1208, Cj1209, and Cj1210) (Fig. 1A).
Cj1208 and Cj1209 overlap by 80 nucleotides, Cj1210 and
Cj1211 overlap by 1 nucleotide, and Cj1209 and Cj1210 are
separated by 8 nucleotides. Cj1208 and Cj1209 encode proteins
of unknown functions, while Cj1210 is a probable membrane
protein belonging to the DedA protein family whose function
is unknown (43). There is a putative promoter upstream of
Cj1208. Based on the consensus RpoD promoter sequence of
C. jejuni (63), the 10, 16, and 35 regions of the promoter
were identified (Fig. 1B). The fact that this promoter was able
to express Cj1211 in JB201C (Fig. 1C) indicates that it is
functional in C. jejuni.
Contribution of Cj1211 to natural transformation. The se-
quence similarity of Cj1211 to ComE3 suggested that Cj1211
could be a competence protein. To examine this hypothesis, a
Cj1211 mutant was constructed and used for natural transfor-
mation. The inactivation of Cj1211 did not change the bacterial
growth rate in MH broth (data not shown). A mutation of
Cj1211 resulted in a significant reduction (P 	 0.01) in the
natural transformation frequency compared with that of the
wild type (Table 3). The reduction was at least 2,175-fold and
832-fold when Tetr DNA and Kanr DNA were used as the
donor DNAs, respectively (Table 3). In fact, no transformants
were observed with JB201 under the conditions used in this
study. Complementation of JB201 with pJB1211 restored the
transformation frequency to the level of the wild type, while
the control vector (pRY108) did not have an effect on trans-
formation (Table 3). Together, these results clearly showed
that Cj1211 plays an important role in the natural transforma-
tion of C. jejuni.
Mutation of Cj1211 did not affect DNA binding and uptake.
Since the mutagenesis of Cj1211 significantly impaired the
natural transformability of C. jejuni, an assay of DNA binding
and uptake was performed to determine which transformation
step was affected by the Cj1211 mutation. The assay was per-
formed with 33P-labeled genomic DNA of C. jejuni NCTC
11168. Compared with the wild-type strain, JB201 did not show
significant changes in DNA binding and uptake (DNA binding
values of 1,470.0
 92.6 cpm ml1 for the wild type and 1,699.3

111.6 cpm ml1 for JB201 and DNA uptake values of 213.3 

48.1 cpm ml1 for the wild type and 220.7 
 18.6 cpm ml1 for
FIG. 2. Sequence alignment of the putative competence domain of
Cj1211 with other ComE3 (ComEC) homologs. B. sub, B. subtilis
ComEC (NCBI accession number BAA12454.1); N. gon, N. gonor-
rhoeae ComA (accession number YP_207438.1); H. pyl, H. pylori
ComE3 (accession number NP_208153.1); C. jej, C. jejuni Cj1211 (ac-
cession number NP_282358.1). The competence domain is based on a
report by Draskovic and Dubnau (13).
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JB201). This result is in contrast to the finding with ComE3 of
H. pylori, in which a mutation of CmeE3 caused a significant
reduction in both DNA binding and uptake (66), but is similar
to observations of N. gonorrhoeae and Pseudomonas stutzeri,
for which mutations of their ComE3 orthologs did not affect
DNA binding and uptake (16, 22).
Role of Cj1211 in mediating horizontal transfer of antibiotic
resistance determinants. Previous studies have shown that a
transfer of antibiotic resistance determinants occurred in bac-
terial cocultures of C. jejuni without supplementing extracel-
lular DNA (10, 62), but the contribution of natural transfor-
mation to this process has not been formally demonstrated.
Since the Cj1211 mutation abolished natural transformation in
C. jejuni, we compared the transfer of antibiotic resistance
markers in the Cj1211 background to that in the Cj1211
background. The coculture of the Cj1211 strains carrying
either aphA3 (for kanamycin resistance) or tet(O) (for tetracy-
cline resistance) generated progenies that were resistant to
both antibiotics within a few hours (Fig. 3A). PCR analysis of
the doubly resistant colonies (10 from each sampling at 3, 8,
and 24 h) revealed that all of the tested colonies harbored the
aphA3 and tet(O) genes inserted into hipO and dcuA, respec-
tively (data not shown), confirming the horizontal transfer of
the antibiotic resistance determinants in the coculture. Wash-
ing the bacterial inocula prior to coculture delayed (P 
0.00047) but did not abolish the emergence of doubly resistant
progenies (Fig. 3B). The addition of DNase I into the cocul-
ture to a final concentration of 30 g ml1 completely pre-
vented the appearance of doubly resistant bacterial cells (Fig.
3C). In contrast to the results obtained with the Cj1211
strains, the coculture experiment using the Cj1211 strains
(JB203 and JB204) did not result in the appearance of doubly
resistant progenies (Fig. 3D). This observation was not due to
changes in antimicrobial susceptibility because the Cj1211 mu-
tation did not affect the MICs of kanamycin and tetracycline in
JB203 and JB204 (data not shown). Furthermore, the acquisi-
tion of aphA3 or tet(O) rendered C. jejuni highly resistant to
kanamycin (MIC  256 g ml1) or tetracycline (MIC  16
g ml1) in both the Cj1211 and Cj1211 backgrounds. To-
gether, these results strongly indicate that DNA exchange oc-
curs actively in Campylobacter cocultures and that the transfer
is mediated by free DNA and natural transformation. These
findings also confirmed that Cj1211 plays a critical role in the
natural transformation of C. jejuni and in the horizontal trans-
fer of genetic materials including antibiotic resistance deter-
minants.
Role of Cj1211 in emergence of FQr mutants. Campylobacter
strains can develop resistance to certain antibiotics through
spontaneous mutations in target genes. For instance, the re-
sistance of Campylobacter to FQs is mediated by spontaneous
mutations in GyrA, which occur at frequencies of 106 to 108
(64). However, the detected mutants could include both bona
fide spontaneous mutants and transformants, because cell
death naturally occurs in bacterial cultures, and the DNA re-
leased from dead FQr cells is conceivably available for the
transformation of the wild-type cells. To determine if natural
transformation influences the frequency of emergence of FQr
mutants in Campylobacter, we compared the rates of mutant
TABLE 3. Contribution of Cj1211 to natural transformation in C. jejuni
Source of donor
DNA
Mean transformation frequency 
 SDa
Wild type JB201 JB201C JB201P
BQ304b (1.74 
 0.76)  105 	0.8  108 (1.41 
 0.91)  105 	3.9  108
JB101c (9.16 
 7.34)  106 	1.1  108 NT NT
a Each frequency represents the means 
 standard deviations of data from triplicate transformations from a single experiment. In all experiments, differences in
transformation frequencies between the wild-type strain and JB201 were consistently observed. NT, not tested due to the presence of the Kanr gene in the
complementing plasmid.
b Conferring tetracycline resistance.
c Conferring kanamycin resistance.
FIG. 3. Natural transformation-mediated transfer of antibiotic re-
sistance determinants in Campylobacter cocultures. (A) Coculture of
C. jejuni JB202 (Kanr) and BQ304 (Tetr) in MH broth with no anti-
biotics. The numbers of bacterial cells that were resistant to both
kanamycin and tetracycline were determined on plates containing both
antibiotics. (B) Effect of washing the inocula on the development of
doubly resistant progenies. JB202 and BQ304 were washed with MH
broth five times before being inoculated into the coculture. (C) Effect
of DNase I treatment on the development of doubly resistant proge-
nies. DNase I was added to the coculture (at a final concentration of
30 g ml1) of JB202 and BQ304. (D) Coculture of C. jejuni JB203
(Kanr) and JB204 (Tetr) in the absence of DNase I treatment. The
Cj1211 gene in both strains was inactivated by insertional mutagenesis.
See Table 1 for detailed information on the strains used in this exper-
iment. The results show the means 
 standard deviations of data from
triplicate samples in a single experiment. Similar patterns of differ-
ences were observed in three independent experiments.
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emergence in the wild type and JB201. Interestingly, JB201
exhibited a significant reduction (approximately 31-fold) in the
frequency of emergence of mutants resistant to ciprofloxacin
(Table 4). This reduction in mutation frequency was not due to
the change in the susceptibility to ciprofloxacin because the
FQr mutants from JB201 and the wild type had the same MICs,
and the inactivation of Cj1211 in FQr mutants did not reduce
the MIC of ciprofloxacin (data not shown). In order to confirm
whether the reduced emergence of FQr mutants in JB201 was
linked to natural transformation, the bacterial culture of the
wild-type strain was treated with DNase I to remove free DNA.
DNase I treatment has been commonly used to assess the
function of natural transformation (42, 50, 51). DNase I was
added to the bacterial culture to a final concentration of 100 g
ml1, which was 3.3 times higher than the concentration used
to inhibit the transfer of Tetr and Kanr by natural transforma-
tion (Fig. 3D). The DNase I treatment did not result in a
significant reduction in the frequency of FQr mutants (Table
4). This result suggests that free DNA was not a major player
in the emergence of FQr mutants, and the reduced emergence
of FQr mutants in JB201 could not be explained by its defect in
natural transformation. In addition, we examined the develop-
ment of spontaneous mutants that are resistant to streptomy-
cin, to which the resistance is associated with point mutations
in the rpsL gene (34). JB201 showed approximately a 129-fold
decrease in the frequency of emergence of streptomycin-resis-
tant mutants (Table 4), suggesting that the Cj1211 mutation
decreases the general spontaneous mutation rates in C. jejuni.
Effect of the Cj1211 mutation on development of FQr
Campylobacter mutants under in vitro treatment. Previously, it
was shown that FQr Campylobacter strains rapidly developed
from an FQ-susceptible population when treated with FQ
antimicrobials (36, 37, 45). The selection of preexisting FQr mu-
tants by the treatment is certainly involved in the development
of resistance, but the role of natural transformation in resis-
tance development is unknown. Since Cj1211 contributes to
natural transformation and the emergence of spontaneous FQr
mutants, we investigated if mutations of Cj1211 affected the
development of FQr mutants when treated with ciprofloxacin.
As shown in Fig. 4, the number of spontaneous FQr mutants
was much lower in JB201 than that in the wild-type strain prior
to exposure to ciprofloxacin. After ciprofloxacin treatment was
initiated, the FQr populations from the wild type and JB201
were both increased. Although the number of FQr mutants
from JB201 was lower than that from the wild-type strain
during the first hours of treatment, the mutant numbers for
both strains were similar after 40 h of antibiotic treatment. This
result suggests that the development of FQr mutants under FQ
treatment is dominated by selection and enrichment, and nat-
ural transformation does not affect the result of selection.
Effect of the Cj1211 mutation on the emergence of FQr
mutants under antibiotic treatment in vivo. To determine the
effect of the Cj1211 mutation on the emergence of FQr mu-
tants under in vivo conditions, two groups of chickens were
inoculated with the wild type or JB201 and treated with a
therapeutic dose of enrofloxacin (50 mg liter1 in drinking
water). JB201 colonized chickens as efficiently as the wild type
(Fig. 5A). Enrofloxacin treatment greatly decreased the colo-
nization levels of both the wild type and JB201 but did not
eliminate the two strains from the chickens (Fig. 5A). In fact,
the Campylobacter populations rebounded after the initial de-
cline. Prior to the treatment, no FQr mutants were detected in
either group. One day after the initiation of antibiotic treat-
ment, FQr mutants could be detected in a few of the treated
chickens (Fig. 5B). The numbers of FQr mutants and chickens
carrying FQr Campylobacter steadily increased during the
treatment. At the last sampling time, all Campylobacter strains
in the chickens were FQr (Fig. 5A and B). There were no
significant differences (P 0.05) between the two groups in the
levels of total Campylobacter and FQr mutants. This finding
indicated that the Cj1211 mutation did not affect the develop-
ment of FQr mutants in chickens treated with enrofloxacin,
which was consistent with the result from the in vitro study
(Fig. 4). Representative Campylobacter colonies selected from
each group were examined for ciprofloxacin MIC by Etest.
Except for the isolates collected on day 7 (1 day after initiation
FIG. 4. Effect of the Cj1211 mutation on the development of FQr
mutants in cultures treated with ciprofloxacin. C. jejuni NCTC 11168
and JB201 were grown in separate culture tubes without ciprofloxacin
for 8 h, and ciprofloxacin was then added to the cultures to a final
concentration of 1 g ml1. The initiation time of ciprofloxacin treat-
ment is indicated by an arrow. Open and solid circles indicate the total
bacterial counts of JB201 and NCTC 11168, respectively, while the
open and solid bars represented the numbers of FQr mutants of NCTC
11168 and JB201, respectively. The results show the means
 standard
deviations of data for triplicate samples in a single experiment. Similar
patterns of results were obtained in three independent experiments.
TABLE 4. Effect of Cj1211 mutation and DNase I treatment on
the emergence of spontaneous mutants that are resistant
to FQ and streptomycin
Type of spontaneous mutant
Mean spontaneous mutation frequency 

SDa
Wild type JB201
FQr mutantsb (3.0 
 1.5)  107 (9.8 
 5.2)  109
FQr mutants with DNase I
treatmentc
(1.9 
 1.1)  107 NT
Strr mutantsd (4.4 
 3.0)  106 (3.4 
 2.2)  108
a Means 
 standard deviations of data for triplicate samples of a single ex-
periment. NT, not tested; Str, streptomycin.
b The concentration of ciprofloxacin used is 1 g ml1; the experiment was
repeated five times.
c DNase I was added to the bacterial suspension at a concentration of 100 g
ml1; the experiment was repeated six times.
d The concentration of streptomycin for plating was 3 g ml1; the experiment
was repeated five times.
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of treatment), the majority of the tested isolates from the later
sampling times had ciprofloxacin MICs of 32 g ml1, and a
few had ciprofloxacin MICs of 4 g ml1. In addition, some
isolates from the JB201-inoculated group were tested by PCR,
and all of the tested isolates carried the insertional mutation in
Cj1211, indicating that the mutation was stably maintained
during in vivo colonization.
DISCUSSION
This study clearly showed that Cj1211 shares significant se-
quence similarity to ComE3, possesses the competence domain
shared by the ComEC (ComE3) homologs (Fig. 2), and is a key
player in the natural transformation of C. jejuni (Table 3).
Based on these findings, we consider Cj1211 to be an inner
membrane transporter protein involved in the transfer of DNA
across the membrane of C. jejuni. Interestingly, the mutation of
Cj1211 did not yield measurable differences in DNA binding
and uptake (see above). In gram-positive bacteria such as B.
subtilis and S. pneumoniae, the ComEC mutation abolished
DNA uptake but did not reduce DNA binding (6, 25). Instead,
DNA accumulated on the bacterial surface of the ComEC
mutants (6, 49). In gram-negative bacteria, the mutagenesis of
ComEC (ComE3) homologs resulted in conflicting results
about DNA binding and uptake. Although the H. pylori
ComE3 mutant exhibited a significant reduction in both DNA
binding and uptake (66), the mutation of ComE3 orthologs in
N. gonorrhoeae and P. stutzeri significantly impaired the natural
transformation of these bacteria without affecting DNA bind-
ing and uptake (16, 22). The discrepancy in DNA uptake be-
tween gram-negative and gram-positive bacteria may be ex-
plained by the differences in the membrane structures and
transformation processes between these two groups of bacte-
ria. In gram-positive bacteria, the mutation of ComEC would
directly impair DNA uptake by blocking DNA transfer from
the external space to the bacterial cytoplasm. However, in
gram-negative bacteria, ComE3 homologs are inner mem-
brane proteins, and the mutation of these proteins should still
allow DNA to be transferred to the periplasmic space. Despite
the inability of ComE3 mutants to transfer the transforming
DNA from the periplasm to the cytosol, the total amount of
DNA within bacterial cells may still be comparable to that in
wild-type strains. This possibility is likely, because the DNA
uptake assay measures the total radioactivity within bacterial
cells without differentiating the DNA in the periplasmic space
from the DNA in the cytosol. Thus, the commonly used DNA
uptake method may not be sensitive enough to determine the
role of ComE3 homologs in DNA internalization into the
cytosol of gram-negative bacteria.
In our previous study, it was shown that C. jejuni possesses a
ComEA homolog (Cj0011c), which is a periplasmic DNA re-
ceptor binding to both double-stranded and single-stranded
DNA with a greater affinity for double-stranded DNA than for
single-stranded DNA (29). The mutation of Cj0011c resulted
in about a 10-fold reduction in the transformation frequency
(29). An early study showed that the mutation of recA com-
pletely abolished the transformation of this bacterium, indicat-
ing that recA plays a critical role in the natural transformation
of Campylobacter, probably by influencing the recombination
step (23). Mutation of VirB10, an N-glycosylated protein en-
coded by the pVir plasmid, decreased the transformation fre-
quency in C. jejuni 81-176 (4, 35). In addition, mutation of the
N-linked protein glycosylation pathway resulted in a significant
reduction (10,000-fold) in transformation frequency in C. je-
juni (35). Recently, transposon mutagenesis identified a dozen
of genes involved in natural transformation (61), several of
which are involved in DNA uptake. Findings in our study
identified a new competence protein that likely forms an inner
membrane channel for the passage of transforming DNA into
the cytosol.
Horizontal gene transfer contributes to the intercellular ex-
change of genetic information and is mediated by natural
transformation, conjugation, and transduction (52, 55). Natu-
ral transformation has long been recognized in Campylobacter
and is regarded as being a main mechanism for mediating
genetic exchange and diversity in Campylobacter (10, 32, 59, 61,
62). Previously, it was shown that the exchange of chromo-
somally encoded antibiotic resistance determinants occurred in
Campylobacter cocultures and in chicken gut colonized by
Campylobacter (10, 62). Although natural transformation was
FIG. 5. Effect of the Cj1211 mutation on the development of FQr
mutants in chickens treated with enrofloxacin. Two groups of chickens
(10 birds/group) were inoculated with wild-type NCTC 11168 (circles)
and JB201 (triangles), respectively. (A) Total Campylobacter numbers
detected in the chickens. (B) Numbers of FQr Campylobacter CFU
detected in the chickens. The period of FQ treatment (from 6 to 11
days postinfection) is indicated with a bar above each panel. Each
symbol represents the Campylobacter number in a single bird. Some
symbols are superimposed. The mean of each group is indicated by a
horizontal bar. The detection limit is approximately 100 CFU/g feces
and is indicated by a dotted line.
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suspected to be a major player in genetic exchange, its role in
mediating the horizontal transfer of antibiotic resistance was
not formally demonstrated. In this study, we showed the key
role of natural transformation in mediating DNA transfer oc-
curring in Campylobacter cocultures (Fig. 3). This conclusion is
based on the fact that the addition of DNase I to the coculture
and the mutation of Cj1211 abolished the development of
doubly resistant mutants (Fig. 3C and 3D). The free DNA
available for natural transformation in the cocultures was likely
released from Campylobacter cells. However, it was unknown if
the free DNA was from dead cells or was secreted by growing
cells. Since Campylobacter is widely present in animals and
birds, and mixed infection by multiple Campylobacter strains
can occur in animal hosts, it is conceivable that natural trans-
formation directly contributes to the spread of antibiotic resis-
tance among different Campylobacter strains.
FQ antimicrobials are important for the clinical treatment of
campylobacteriosis. However, Campylobacter has become in-
creasingly resistant to FQ antimicrobials. In Campylobacter
strains, resistance to FQs is conferred by gyrase mutations and
the function of the multidrug efflux pump CmeABC (19, 36,
57). Campylobacter does not have ParC and ParE, and single
point mutations in the gyrA gene can confer high-level resis-
tance to FQ antimicrobials (36, 44, 45, 47, 57). FQ resistance
occurs at a rate as high as 106 from an FQ-susceptible pop-
ulation (64), but it is technically difficult to directly know if the
detected mutants are spontaneous mutants, transformation-
generated mutants, or both. To address this question, we
added DNase I to the bacterial cultures, and this treatment did
not result in a significant change in the frequency of emergence
of FQr mutants (Table 4), indicating that natural transforma-
tion does not play a major role in the emergence of FQr
mutants. Interestingly, the insertional mutagenesis of Cj1211
substantially reduced the frequency of emergence of FQr mu-
tants (Table 4), but the reduction cannot be explained by the
defect of the Cj1211 mutant in natural transformation because
DNase treatment did not influence the rate of mutant emer-
gence. However, it is possible that Cj1211, a predicted inner
membrane protein, may interact with other cytoplasmic pro-
teins involved in DNA transformation and recombination and
thus affect both spontaneous mutation and transformation in
Campylobacter. In B. subtilis, competence proteins (ComGA,
ComFA, YwpH, and RecA) colocalize at the bacterial poles
(26, 31), suggesting spatial proximity or protein interactions
between membrane-associated competence proteins and cyto-
plasmic proteins (e.g., RecA). A recent study indeed indicated
that membrane-associated competence proteins (ComEC,
ComFA, ComGA, and ComEA) interact with cytoplasmic sol-
uble proteins (RecA, DprA, SsbB, and YjbF) and that a dele-
tion of one competence protein destabilizes the partner pro-
teins and the functional complex in B. subtilis (33). If Cj1211
forms a functional complex with other cytoplasmic proteins in
C. jejuni, such as RecA, which is involved in both natural
transformation and spontaneous mutation (5, 8, 54), the loss of
Cj1211 may affect the function of RecA and consequently
influence the spontaneous mutation rates. This possibility is
high because the mutagenesis of Cj1211 also reduced the
emergence of streptomycin-resistant mutants (Table 4), sug-
gesting that the general mutation rate was decreased in the
Cj1211 mutant. How Cj1211 interacts with other competence
proteins in C. jejuni will be examined in future studies.
Multiple studies showed that when Campylobacter-infected
animals were treated with FQ antimicrobials, FQr Campy-
lobacter mutants rapidly emerged and populated the treated
animals (11, 28, 36, 37). The rapid emergence of FQr mutants
under selective pressure may have contributed to the high
prevalence of FQr Campylobacter strains on a worldwide scale.
The development of FQr Campylobacter from an FQ-suscep-
tible population under FQ treatment certainly involves the
selection of preexisting spontaneous mutants, but whether nat-
ural transformation is involved in the process is unknown. By
taking advantage of the Cj1211 mutant, which is defective in
natural transformation, we conducted both in vitro experi-
ments and animal studies to determine if natural transforma-
tion affects the development of FQr mutants under selection
pressure. Prior to exposure to ciprofloxacin, the number of
naturally occurring FQr mutants in the bacterial population
was quite low (Fig. 4). Once the antibiotic treatment was ini-
tiated, the majority of the FQ-susceptible bacterial cells were
killed, and a large amount of free DNA would be released
from the dead cells into the culture supernatant. It is conceiv-
able that the free DNA would be available to transform the
FQr cells, but the transformants would be quickly killed by
ciprofloxacin. Thus, the continuous presence of ciprofloxacin
in the cultures eventually eliminated the impact of natural
transformation and enriched the FQr population (Fig. 4). The
in vitro findings were confirmed by the animal treatment study,
which showed that the dynamics of development of FQr
Campylobacter were similar between the wild-type strain and
JB201 when the chickens were treated with enrofloxacin (Fig.
5). Together, these results suggest that natural transformation
does not have a major impact on the development of FQr
Campylobacter strains under FQ-selective pressure.
In conclusion, our study identified Cj1211 as being a new
competence factor in C. jejuni and proved the role of natural
transformation in the horizontal transfer of antibiotic resis-
tance determinants. In addition, we showed that Cj1211 influ-
ences the emergence of spontaneous FQr mutants, but this
effect appears to be independent of its role in natural trans-
formation. Furthermore, we showed that natural transforma-
tion does not play a significant role in the development of FQr
Campylobacter strains resulting from FQ treatments. These
findings provide new insights into the mechanisms of natural
transformation and antibiotic resistance development in
Campylobacter.
ACKNOWLEDGMENTS
We thank Baoqing Guo for constructing the BQ304 mutant used in
this study.
This work was supported by National Institutes of Health grant
RO1DK063008 and National Research Initiative competitive grant
2007-35201-18278 from the USDA Cooperative State Research, Edu-
cation, and Extension Service.
REFERENCES
1. Atterbury, R. J., P. L. Connerton, C. E. Dodd, C. E. Rees, and I. F. Conner-
ton. 2003. Isolation and characterization of Campylobacter bacteriophages
from retail poultry. Appl. Environ. Microbiol. 69:4511–4518.
2. Avrain, L., C. Vernozy-Rozand, and I. Kempf. 2004. Evidence for natural
horizontal transfer of tetO gene between Campylobacter jejuni strains in
chickens. J. Appl. Microbiol. 97:134–140.
2706 JEON ET AL. ANTIMICROB. AGENTS CHEMOTHER.
 o
n
 Septem
ber 29, 2017 by IO
W
A STATE UNIVERSITY
http://aac.asm
.org/
D
ow
nloaded from
 
3. Bacon, D. J., R. A. Alm, D. H. Burr, L. Hu, D. J. Kopecko, C. P. Ewing, T. J.
Trust, and P. Guerry. 2000. Involvement of a plasmid in virulence of Campy-
lobacter jejuni 81-176. Infect. Immun. 68:4384–4390.
4. Bacon, D. J., R. A. Alm, L. Hu, T. E. Hickey, C. P. Ewing, R. A. Batchelor, T. J.
Trust, and P. Guerry. 2002. DNA sequence and mutational analyses of the pVir
plasmid of Campylobacter jejuni 81-176. Infect. Immun. 70:6242–6250.
5. Berge´, M., I. Mortier-Barrie`re, B. Martin, and J. P. Claverys. 2003. Trans-
formation of Streptococcus pneumoniae relies on DprA- and RecA-depen-
dent protection of incoming DNA single strands. Mol. Microbiol. 50:527–
536.
6. Berge´, M., M. Moscoso, M. Prudhomme, B. Martin, and J. P. Claverys. 2002.
Uptake of transforming DNA in gram-positive bacteria: a view from Strep-
tococcus pneumoniae. Mol. Microbiol. 45:411–421.
7. Carfi, A., S. Pares, E. Duee, M. Galleni, C. Duez, J. M. Frere, and O.
Dideberg. 1995. The 3-D structure of a zinc metallo-beta-lactamase from
Bacillus cereus reveals a new type of protein fold. EMBO J. 14:4914–4921.
8. Chen, I., P. J. Christie, and D. Dubnau. 2005. The ins and outs of DNA
transfer in bacteria. Science 310:1456–1460.
9. Davies, J. 1994. Inactivation of antibiotics and the dissemination of resis-
tance genes. Science 264:375–382.
10. de Boer, P., J. A. Wagenaar, R. P. Achterberg, J. P. van Putten, L. M.
Schouls, and B. Duim. 2002. Generation of Campylobacter jejuni genetic
diversity in vivo. Mol. Microbiol. 44:351–359.
11. Delsol, A. A., J. Sunderland, M. J. Woodward, L. Pumbwe, L. J. Piddock, and
J. M. Roe. 2004. Emergence of fluoroquinolone resistance in the native
Campylobacter coli population of pigs exposed to enrofloxacin. J. Antimi-
crob. Chemother. 53:872–874.
12. Dorrell, N., J. A. Mangan, K. G. Laing, J. Hinds, D. Linton, H. Al Ghusein,
B. G. Barrell, J. Parkhill, N. G. Stoker, A. V. Karlyshev, P. D. Butcher, and
B. W. Wren. 2001. Whole genome comparison of Campylobacter jejuni hu-
man isolates using a low-cost microarray reveals extensive genetic diversity.
Genome Res. 11:1706–1715.
13. Draskovic, I., and D. Dubnau. 2005. Biogenesis of a putative channel pro-
tein, ComEC, required for DNA uptake: membrane topology, oligomeriza-
tion and formation of disulphide bonds. Mol. Microbiol. 55:881–896.
14. Dubnau, D. 1999. DNA uptake in bacteria. Annu. Rev. Microbiol. 53:217–
244.
15. Dubnau, D., and R. Provvedi. 2000. Internalizing DNA. Res. Microbiol.
151:475–480.
16. Facius, D., and T. F. Meyer. 1993. A novel determinant (comA) essential for
natural transformation competence in Neisseria gonorrhoeae and the effect of
a comA defect on pilin variation. Mol. Microbiol. 10:699–712.
17. Fouts, D. E., E. F. Mongodin, R. E. Mandrell, W. G. Miller, D. A. Rasko, J.
Ravel, L. M. Brinkac, R. T. DeBoy, C. T. Parker, S. C. Daugherty, R. J.
Dodson, A. S. Durkin, R. Madupu, S. A. Sullivan, J. U. Shetty, M. A. Ayodeji,
A. Shvartsbeyn, M. C. Schatz, J. H. Badger, C. M. Fraser, and K. E. Nelson.
2005. Major structural differences and novel potential virulence mechanisms
from the genomes of multiple Campylobacter species. PLoS Biol. 3:e15.
18. Frost, L. S., R. Leplae, A. O. Summers, and A. Toussaint. 2005. Mobile
genetic elements: the agents of open source evolution. Nat. Rev. Microbiol.
3:722–732.
19. Ge, B., P. F. McDermott, D. G. White, and J. Meng. 2005. Role of efflux
pumps and topoisomerase mutations in fluoroquinolone resistance in
Campylobacter jejuni and Campylobacter coli. Antimicrob. Agents Che-
mother. 49:3347–3354.
20. Gibreel, A., and D. E. Taylor. 2006. Macrolide resistance in Campylobacter
jejuni and Campylobacter coli. J. Antimicrob. Chemother. 58:243–255.
21. Grajewski, B. A., J. W. Kusek, and H. M. Gelfand. 1985. Development of a
bacteriophage typing system for Campylobacter jejuni and Campylobacter
coli. J. Clin. Microbiol. 22:13–18.
22. Graupner, S., and W. Wackernagel. 2001. Identification and characterization
of novel competence genes comA and exbB involved in natural genetic
transformation of Pseudomonas stutzeri. Res. Microbiol. 152:451–460.
23. Guerry, P., P. M. Pope, D. H. Burr, J. Leifer, S. W. Joseph, and A. L.
Bourgeois. 1994. Development and characterization of recA mutants of
Campylobacter jejuni for inclusion in attenuated vaccines. Infect. Immun.
62:426–432.
24. Guerry, P., R. Yao, R. A. Alm, D. H. Burr, and T. J. Trust. 1994. Systems of
experimental genetics for Campylobacter species. Methods Enzymol. 235:
474–481.
25. Hahn, J., G. Inamine, Y. Kozlov, and D. Dubnau. 1993. Characterization of
comE, a late competence operon of Bacillus subtilis required for the binding
and uptake of transforming DNA. Mol. Microbiol. 10:99–111.
26. Hahn, J., B. Maier, B. J. Haijema, M. Sheetz, and D. Dubnau. 2005. Trans-
formation proteins and DNA uptake localize to the cell poles in Bacillus
subtilis. Cell 122:59–71.
27. Hughes, R. A., and D. R. Cornblath. 2005. Guillain-Barre syndrome. Lancet
366:1653–1666.
28. Humphrey, T. J., F. Jorgensen, J. A. Frost, H. Wadda, G. Domingue, N. C.
Elviss, D. J. Griggs, and L. J. Piddock. 2005. Prevalence and subtypes of
ciprofloxacin-resistant Campylobacter spp. in commercial poultry flocks be-
fore, during, and after treatment with fluoroquinolones. Antimicrob. Agents
Chemother. 49:690–698.
29. Jeon, B., and Q. Zhang. 2007. Cj0011c, a periplasmic single- and double-
stranded DNA-binding protein, contributes to natural transformation in
Campylobacter jejuni. J. Bacteriol. 189:7399–7407.
30. Khakhria, R., and H. Lior. 1992. Extended phage-typing scheme for Campy-
lobacter jejuni and Campylobacter coli. Epidemiol. Infect. 108:403–414.
31. Kidane, D., and P. L. Graumann. 2005. Intracellular protein and DNA
dynamics in competent Bacillus subtilis cells. Cell 122:73–84.
32. Kim, J. S., D. K. Carver, and S. Kathariou. 2006. Natural transformation-
mediated transfer of erythromycin resistance in Campylobacter coli strains
from turkeys and swine. Appl. Environ. Microbiol. 72:1316–1321.
33. Kramer, N., J. Hahn, and D. Dubnau. 2007. Multiple interactions among the
competence proteins of Bacillus subtilis. Mol. Microbiol. 65:454–464.
34. Lambert, P. A. 2005. Bacterial resistance to antibiotics: modified target sites.
Adv. Drug Deliv. Rev. 57:1471–1485.
35. Larsen, J. C., C. Szymanski, and P. Guerry. 2004. N-linked protein glyco-
sylation is required for full competence in Campylobacter jejuni 81-176. J.
Bacteriol. 186:6508–6514.
36. Luo, N., O. Sahin, J. Lin, L. O. Michel, and Q. Zhang. 2003. In vivo selection
of Campylobacter isolates with high levels of fluoroquinolone resistance
associated with gyrA mutations and the function of the CmeABC efflux
pump. Antimicrob. Agents Chemother. 47:390–394.
37. McDermott, P. F., S. M. Bodeis, L. L. English, D. G. White, R. D. Walker, S.
Zhao, S. Simjee, and D. D. Wagner. 2002. Ciprofloxacin resistance in Campy-
lobacter jejuni evolves rapidly in chickens treated with fluoroquinolones.
J. Infect. Dis. 185:837–840.
38. Mead, P. S., L. Slutsker, V. Dietz, L. F. McCaig, J. S. Bresee, C. Shapiro,
P. M. Griffin, and R. V. Tauxe. 1999. Food-related illness and death in the
United States. Emerg. Infect. Dis. 5:607–625.
39. Miller, W. G., A. H. Bates, S. T. Horn, M. T. Brandl, M. R. Wachtel, and
R. E. Mandrell. 2000. Detection on surfaces and in Caco-2 cells of Campy-
lobacter jejuni cells transformed with new gfp, yfp, and cfp marker plasmids.
Appl. Environ. Microbiol. 66:5426–5436.
40. Normark, B. H., and S. Normark. 2002. Evolution and spread of antibiotic
resistance. J. Intern. Med. 252:91–106.
41. Notani, N. K., J. K. Setlow, V. R. Joshi, and D. P. Allison. 1972. Molecular
basis for the transformation defects in mutants of Haemophilus influenzae. J.
Bacteriol. 110:1171–1180.
42. Oyarzabal, O. A., R. Rad, and S. Backert. 2007. Conjugative transfer of
chromosomally encoded antibiotic resistance from Helicobacter pylori to
Campylobacter jejuni. J. Clin. Microbiol. 45:402–408.
43. Parkhill, J., B. W. Wren, K. Mungall, J. M. Ketley, C. Churcher, D. Basham,
T. Chillingworth, R. M. Davies, T. Feltwell, S. Holroyd, K. Jagels, A. V.
Karlyshev, S. Moule, M. J. Pallen, C. W. Penn, M. A. Quail, M. A. Rajan-
dream, K. M. Rutherford, A. H. van Vliet, S. Whitehead, and B. G. Barrell.
2000. The genome sequence of the food-borne pathogen Campylobacter
jejuni reveals hypervariable sequences. Nature 403:665–668.
44. Payot, S., J. M. Bolla, D. Corcoran, S. Fanning, F. Megraud, and Q. Zhang.
2006. Mechanisms of fluoroquinolone and macrolide resistance in Campy-
lobacter spp. Microbes Infect. 8:1967–1971.
45. Payot, S., A. Cloeckaert, and E. Chaslus-Dancla. 2002. Selection and char-
acterization of fluoroquinolone-resistant mutants of Campylobacter jejuni
using enrofloxacin. Microb. Drug Resist. 8:335–343.
46. Pestova, E. V., and D. A. Morrison. 1998. Isolation and characterization of
three Streptococcus pneumoniae transformation-specific loci by use of a lacZ
reporter insertion vector. J. Bacteriol. 180:2701–2710.
47. Piddock, L. J., V. Ricci, L. Pumbwe, M. J. Everett, and D. J. Griggs. 2003.
Fluoroquinolone resistance in Campylobacter species from man and animals:
detection of mutations in topoisomerase genes. J. Antimicrob. Chemother.
51:19–26.
48. Pratt, A., and V. Korolik. 2005. Tetracycline resistance of Australian Campy-
lobacter jejuni and Campylobacter coli isolates. J. Antimicrob. Chemother.
55:452–460.
49. Provvedi, R., I. Chen, and D. Dubnau. 2001. NucA is required for DNA
cleavage during transformation of Bacillus subtilis. Mol. Microbiol. 40:634–
644.
50. Sikorski, J., S. Graupner, M. G. Lorenz, and W. Wackernagel. 1998. Natural
genetic transformation of Pseudomonas stutzeri in a non-sterile soil. Micro-
biology 144:569–576.
51. Stewart, G. J., and C. D. Sinigalliano. 1990. Detection of horizontal gene
transfer by natural transformation in native and introduced species of bac-
teria in marine and synthetic sediments. Appl. Environ. Microbiol. 56:1818–
1824.
52. Summers, A. O. 2006. Genetic linkage and horizontal gene transfer, the roots
of the antibiotic multi-resistance problem. Anim. Biotechnol. 17:125–135.
53. Taylor, D. E., S. A. De Grandis, M. A. Karmali, and P. C. Fleming. 1981.
Transmissible plasmids from Campylobacter jejuni. Antimicrob. Agents Che-
mother. 19:831–835.
54. Tessman, E. S., I. Tessman, P. K. Peterson, and J. D. Forestal. 1986. Roles
of RecA protease and recombinase activities of Escherichia coli in sponta-
VOL. 52, 2008 TRANSFORMATION AND ANTIBIOTIC RESISTANCE IN C. JEJUNI 2707
 o
n
 Septem
ber 29, 2017 by IO
W
A STATE UNIVERSITY
http://aac.asm
.org/
D
ow
nloaded from
 
neous and UV-induced mutagenesis and in Weigle repair. J. Bacteriol.
168:1159–1164.
55. Thomas, C. M., and K. M. Nielsen. 2005. Mechanisms of, and barriers to,
horizontal gene transfer between bacteria. Nat. Rev. Microbiol. 3:711–721.
56. Velazquez, J. B., A. Jimenez, B. Chomon, and T. G. Villa. 1995. Incidence
and transmission of antibiotic resistance in Campylobacter jejuni and Campy-
lobacter coli. J. Antimicrob. Chemother. 35:173–178.
57. Wang, Y., W. M. Huang, and D. E. Taylor. 1993. Cloning and nucleotide
sequence of the Campylobacter jejuni gyrA gene and characterization of
quinolone resistance mutations. Antimicrob. Agents Chemother. 37:457–
463.
58. Wang, Y., and D. E. Taylor. 1990. Chloramphenicol resistance in Campy-
lobacter coli: nucleotide sequence, expression, and cloning vector construc-
tion. Gene 94:23–28.
59. Wang, Y., and D. E. Taylor. 1990. Natural transformation in Campylobacter
species. J. Bacteriol. 172:949–955.
60. Wassenaar, T. M., B. N. Fry, and B. A. van der Zeijst. 1993. Genetic
manipulation of Campylobacter: evaluation of natural transformation and
electro-transformation. Gene 132:131–135.
61. Wiesner, R. S., D. R. Hendrixson, and V. J. DiRita. 2003. Natural transfor-
mation of Campylobacter jejuni requires components of a type II secretion
system. J. Bacteriol. 185:5408–5418.
62. Wilson, D. L., J. A. Bell, V. B. Young, S. R. Wilder, L. S. Mansfield, and J. E.
Linz. 2003. Variation of the natural transformation frequency of Campy-
lobacter jejuni in liquid shake culture. Microbiology 149:3603–3615.
63. Wo¨sten, M. M., M. Boeve, M. G. Koot, A. C. van Nuenen, and B. A. van der
Zeijst. 1998. Identification of Campylobacter jejuni promoter sequences. J.
Bacteriol. 180:594–599.
64. Yan, M., O. Sahin, J. Lin, and Q. Zhang. 2006. Role of the CmeABC efflux
pump in the emergence of fluoroquinolone-resistant Campylobacter under
selection pressure. J. Antimicrob. Chemother. 58:1154–1159.
65. Yao, R., R. A. Alm, T. J. Trust, and P. Guerry. 1993. Construction of new
Campylobacter cloning vectors and a new mutational cat cassette. Gene
130:127–130.
66. Yeh, Y. C., T. L. Lin, K. C. Chang, and J. T. Wang. 2003. Characterization
of a ComE3 homologue essential for DNA transformation in Helicobacter
pylori. Infect. Immun. 71:5427–5431.
67. Yuki, N. 2005. Carbohydrate mimicry: a new paradigm of autoimmune dis-
eases. Curr. Opin. Immunol. 17:577–582.
2708 JEON ET AL. ANTIMICROB. AGENTS CHEMOTHER.
 o
n
 Septem
ber 29, 2017 by IO
W
A STATE UNIVERSITY
http://aac.asm
.org/
D
ow
nloaded from
 
